Found 41 matching trials
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis N/A Taxane-based agents are widely used in the treatment of esophageal squamous...
Show More Location
West China Hospital
Learn More & Join Trial
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients PHASE2 The purpose of this Phase 1b/2 study is to evaluate the safety and tolerabi...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC PHASE2 This is a prospective, single-arm, investigator-initiated clinical study (I...
Show More Location
Multiple Locations
Learn More & Join Trial
Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer PHASE2 This is a Multi-center, Open-label, Randomized Controlled,phase 2 clinical ...
Show More Location
Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC PHASE2 This study is to evaluate the efficacy and safety of QL1706 plus albumin-bo...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer PHASE3 The study is being conducted to evaluate VEGFR BP102 with nab-paclitaxe or ...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma PHASE2 This is a single arm phase II study. All patients will receive 3 cycles of ...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma PHASE3 The purpose of this study is to evaluate the safety and efficacy of atebime...
Show More Location
Clearview Cancer Institute
Learn More & Join Trial
A Study of ASP3082 in Adults With Advanced Solid Tumors PHASE1 This is an open-label study. This means that people in this study and clini...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial